Enabling access to molecular monitoring for chronic myeloid leukemia patients is cost effective in China

OBJECTIVE: To determine the cost effectiveness of molecular monitoring in patients with chronic myeloid leukemia in the chronic phase (CML-CP) compared to no molecular monitoring from a Chinese payer perspective. METHODS: Analyses were conducted using a semi-Markov model with a 50-year time horizon....

Descripción completa

Detalles Bibliográficos
Autores principales: Maheshwari, Vikalp Kumar, Slader, Cassandra, Dani, Nidhi, Gkitzia, Christina, Yuan, Quan, Xiong, Tengbin, Liu, Yu, Viana, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544861/
https://www.ncbi.nlm.nih.gov/pubmed/34695169
http://dx.doi.org/10.1371/journal.pone.0259076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544861/
https://www.ncbi.nlm.nih.gov/pubmed/34695169
http://dx.doi.org/10.1371/journal.pone.0259076

Ejemplares similares